Eminence Capital, LP Danaher Corp Transaction History

Eminence Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $105 Million - $121 Million	-842,309 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $78.3 Million - $106 Million	-801,991 Reduced 48.77%	842,309 $111 Million
Q4 2018 Feb 14, 2019	BUY	$94.85 - $109.54 $54.8 Million - $63.2 Million	577,300 Added 54.1%	1,644,300 $170 Million
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $105 Million - $116 Million	1,067,000 New	1,067,000 $116 Million

2,493

532M

7.25M

4.28M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $144B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.